Your browser doesn't support javascript.
loading
Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit ß-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease.
Makhaeva, Galina F; Kovaleva, Nadezhda V; Rudakova, Elena V; Boltneva, Natalia P; Lushchekina, Sofya V; Astakhova, Tatiana Yu; Timokhina, Elena N; Serebryakova, Olga G; Shchepochkin, Alexander V; Averkov, Maxim A; Utepova, Irina A; Demina, Nadezhda S; Radchenko, Eugene V; Palyulin, Vladimir A; Fisenko, Vladimir P; Bachurin, Sergey O; Chupakhin, Oleg N; Charushin, Valery N; Richardson, Rudy J.
Afiliación
  • Makhaeva GF; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Kovaleva NV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Rudakova EV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Boltneva NP; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Lushchekina SV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Astakhova TY; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia.
  • Timokhina EN; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia.
  • Serebryakova OG; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia.
  • Shchepochkin AV; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Averkov MA; Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia.
  • Utepova IA; Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia.
  • Demina NS; Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia.
  • Radchenko EV; Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia.
  • Palyulin VA; Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia.
  • Fisenko VP; Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia.
  • Bachurin SO; Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia.
  • Chupakhin ON; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
  • Charushin VN; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Richardson RJ; Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia.
Front Pharmacol ; 14: 1219980, 2023.
Article en En | MEDLINE | ID: mdl-37654616
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza